Researchers from the University of New Hampshire looked at the developmental process of the cerebral cortex—the outermost ...
Columnist Dagmar Munn says she has often felt out of place in the ALS community because of the slower pace of her disease ...
The study will measure the impact of Cognixion's novel combination of BCI, AI and AR technology on the ability of amyotrophic lateral sclerosis ...
IEEE Spectrum on MSN20h
New Brain Tech Gives Voice to ALS PatientsA myotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects muscle control, and most ...
Among participants who met the core RESTORE-ALS Trial criteria (e.g., baseline serum NfL > 33 pg/mL, TRICALS risk score range between –6.5 and –2.5, baseline slow vital capacity > 60%, and symptom ...
Startup Cognixion, which has developed a noninvasive brain-computer interface, has begun a clinical trial for patients with ...
A new study compares three types of blood biomarkers: neurofilament light chain proteins, glial acidic proteins and phosphorylated tau 181.
Treatment with donanemab (Kisunla) raised the risk of amyloid-related imaging abnormalities (ARIA) in people with early ...
Tris Pharma announced positive topline results from the ALLEVIATE-2 phase III clinical trial of investigational cebranopadol to treat moderate-to-severe acute pain after bunionectomy surgery. Axonal ...
Northwestern Medicine scientists have uncovered new insights into how neurofilaments act like Velcro in neurodegenerative ...
Paradromics announced today that it selected investigators for an upcoming clinical study of its brain-computer interface ...
Pathmaker's MyoRegulator is designed to ease hyperexcitability and delivers an electrical current to the spinal cord and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback